SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
Stephens Investment Management Group LLC 1,704,698$46,998,5240.77%
Bruce & Co., Inc. 82,105$2,263,6340.77%
Parkman Healthcare Partners LLC 138,172$3,809,4020.70%
Seaport Global Advisors, LLC 7,942$218,9610.66%
Phocas Financial Corp. 157,066$4,330,0000.63%
THIRD AVENUE MANAGEMENT LLC 116,549$3,272,6960.55%
Virtus Investment Advisers, Inc. 29,148$803,6100.55%
HUSSMAN STRATEGIC ADVISORS, INC. 93,600$2,580,5520.49%
Mitsubishi UFJ Asset Management (UK) Ltd. 24,000$6620.47%
Mystic Asset Management, Inc. 29,840$822,6890.46%
External links

This page lists SUPERNUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view SUPERNUS PHARMACEUTICALS INC's shareholder history, click here.